Congresses
Cardiovascular (CV)
American College of Cardiology (ACC) 2026
Cardiovascular (CV)
Global Cardiovascular Clinical Trialists Forum (CVCT) 2025
Cardiovascular (CV)
American Heart Association (AHA) 2025
Cardiovascular (CV)
European Society of Cardiology (ESC) 2025
Publications
Cardiovascular (CV)
Add-on Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial
Journal of the American Medical Association
Cardiovascular (CV)
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial
The Journal of the American Medical Association
Cardiovascular (CV)
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
New England Journal of Medicine
Cardiovascular (CV)
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease
Hypertension
Cardiovascular (CV)
No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension
Clinical Science
Cardiovascular (CV)
RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models
The Journal of Clinical Investigation
